ArticleBMC pulmonary medicine2024

The assessment of dupilumab in children with moderate-to-severe asthma and comorbid type 2 inflammatory diseases.

Tingting Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.